세계의 탈회 동종이식편 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Demineralized Allografts was estimated to be worth US$ 583 million in 2024 and is forecast to a readjusted size of US$ 672 million by 2031 with a CAGR of 2.0% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Demineralized Allografts cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Demineralized Allografts is tissue harvested from one individual and implanted into another of the same species. In a search for an adequate substitute for autogenous bone, cadaveric allograft has been a viable option. Structural and morselized forms are available and prepared as either fresh-frozen or freeze-dried. These grafts provide a structural framework or scaffold for host tissue to grow, hence making allograft osteoconductive. Conversely, its osteoinductive properties are mediocre at best. Upon implantation, the host is expected to experience an intricate immune response. Freezing or freeze-drying the allograft is crucial in minimizing this reaction; however, the fundamental properties of the material may be altered. In 2024, global Demineralized Allografts production reached approximately 20.1 m units, with an average global market price of around US$ 20.9 perunit

Structural growth in orthopedic and dental procedures-amplified by aging demographics and minimally invasive techniques-is expanding penetration of demineralized allografts across spinal fusion, trauma repair, and implant-related augmentation. Public company reports and broker coverage highlight bundled solutions with fixation systems, standardized clinical pathways, and product innovation (e.g., fiberized DBM for better scaffolding) as dual engines of value. Concurrently, government improvements in donation systems, tissue bank governance, and hospital quality controls enhance raw material availability and clinician confidence, underpinning scalable adoption and international market access.

Volatility in donor supply, heterogeneous regulations, and cross-border approval gaps introduce uncertainty-different jurisdictions impose varying requirements on labeling and clinical evidence, elevating registration and operating costs. Rising expenses in sourcing, sterilization, and cold-chain logistics pressure margins for smaller players, while leaders retain pricing power through channels, KOL networks, and clinical evidence. Tightening compliance reviews and hospital procurement initiatives increase price transparency, pushing manufacturers to invest more in product consistency, clinical data, and end-to-end traceability.

Clinicians prioritize "ready-to-use, moldable, and predictable" solutions, favoring integrated packs that combine DBM with carriers, synthetics, and barrier membranes. Fiberized, compressible formats and hybrid use with autograft/synthetics are gaining share in spine and dental indications. Digital workflows and consensus guidelines steer evidence-based selection, with hospitals valuing multicenter follow-up and real-world data. Infection control and compliance traceability-sterility assurance, barcode tracking, and temperature logs-are emerging as key purchasing criteria, while premium segments show a rising bias toward bioactivity and processing consistency.

This report aims to provide a comprehensive presentation of the global market for Demineralized Allografts, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Demineralized Allografts by region & country, by Type, and by Application.

The Demineralized Allografts market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Demineralized Allografts.

Market Segmentation

By Company

• Medtronic
• J &J (DePuy Synthes)
• Zimmer
• Stryker Corporation
• Straumann
• RTI Surgical
• Wright Medical Group
• SeaSpine
• Xtant Medical
• Hans Biomed

Segment by Type

• Gel
• Putty
• Putty with Chips
• Others

Segment by Application

• Dental
• Spine Surgery
• Trauma Surgery

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Demineralized Allografts manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Demineralized Allografts in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Demineralized Allografts in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Demineralized Allografts Product Introduction
• 1.2 Global Demineralized Allografts Market Size Forecast
  • 1.2.1 Global Demineralized Allografts Sales Value (2020-2031)
  • 1.2.2 Global Demineralized Allografts Sales Volume (2020-2031)
  • 1.2.3 Global Demineralized Allografts Sales Price (2020-2031)
• 1.3 Demineralized Allografts Market Trends & Drivers
  • 1.3.1 Demineralized Allografts Industry Trends
  • 1.3.2 Demineralized Allografts Market Drivers & Opportunity
  • 1.3.3 Demineralized Allografts Market Challenges
  • 1.3.4 Demineralized Allografts Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Demineralized Allografts Players Revenue Ranking (2024)
• 2.2 Global Demineralized Allografts Revenue by Company (2020-2025)
• 2.3 Global Demineralized Allografts Players Sales Volume Ranking (2024)
• 2.4 Global Demineralized Allografts Sales Volume by Company Players (2020-2025)
• 2.5 Global Demineralized Allografts Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Demineralized Allografts Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Demineralized Allografts Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Demineralized Allografts
• 2.9 Demineralized Allografts Market Competitive Analysis
  • 2.9.1 Demineralized Allografts Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Demineralized Allografts Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Demineralized Allografts as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Gel
  • 3.1.2 Putty
  • 3.1.3 Putty with Chips
  • 3.1.4 Others
• 3.2 Global Demineralized Allografts Sales Value by Type
  • 3.2.1 Global Demineralized Allografts Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Demineralized Allografts Sales Value, by Type (2020-2031)
  • 3.2.3 Global Demineralized Allografts Sales Value, by Type (%) (2020-2031)
• 3.3 Global Demineralized Allografts Sales Volume by Type
  • 3.3.1 Global Demineralized Allografts Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Demineralized Allografts Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Demineralized Allografts Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Demineralized Allografts Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Dental
  • 4.1.2 Spine Surgery
  • 4.1.3 Trauma Surgery
• 4.2 Global Demineralized Allografts Sales Value by Application
  • 4.2.1 Global Demineralized Allografts Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Demineralized Allografts Sales Value, by Application (2020-2031)
  • 4.2.3 Global Demineralized Allografts Sales Value, by Application (%) (2020-2031)
• 4.3 Global Demineralized Allografts Sales Volume by Application
  • 4.3.1 Global Demineralized Allografts Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Demineralized Allografts Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Demineralized Allografts Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Demineralized Allografts Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Demineralized Allografts Sales Value by Region
  • 5.1.1 Global Demineralized Allografts Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Demineralized Allografts Sales Value by Region (2020-2025)
  • 5.1.3 Global Demineralized Allografts Sales Value by Region (2026-2031)
  • 5.1.4 Global Demineralized Allografts Sales Value by Region (%), (2020-2031)
• 5.2 Global Demineralized Allografts Sales Volume by Region
  • 5.2.1 Global Demineralized Allografts Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Demineralized Allografts Sales Volume by Region (2020-2025)
  • 5.2.3 Global Demineralized Allografts Sales Volume by Region (2026-2031)
  • 5.2.4 Global Demineralized Allografts Sales Volume by Region (%), (2020-2031)
• 5.3 Global Demineralized Allografts Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Demineralized Allografts Sales Value, 2020-2031
  • 5.4.2 North America Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Demineralized Allografts Sales Value, 2020-2031
  • 5.5.2 Europe Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Demineralized Allografts Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Demineralized Allografts Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Demineralized Allografts Sales Value, 2020-2031
  • 5.7.2 South America Demineralized Allografts Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Demineralized Allografts Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Demineralized Allografts Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Demineralized Allografts Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Demineralized Allografts Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Demineralized Allografts Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Demineralized Allografts Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Demineralized Allografts Sales Value, 2020-2031
  • 6.3.2 United States Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Demineralized Allografts Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Demineralized Allografts Sales Value, 2020-2031
  • 6.4.2 Europe Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Demineralized Allografts Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Demineralized Allografts Sales Value, 2020-2031
  • 6.5.2 China Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Demineralized Allografts Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Demineralized Allografts Sales Value, 2020-2031
  • 6.6.2 Japan Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Demineralized Allografts Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Demineralized Allografts Sales Value, 2020-2031
  • 6.7.2 South Korea Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Demineralized Allografts Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Demineralized Allografts Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Demineralized Allografts Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Demineralized Allografts Sales Value, 2020-2031
  • 6.9.2 India Demineralized Allografts Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Demineralized Allografts Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Medtronic
  • 7.1.1 Medtronic Company Information
  • 7.1.2 Medtronic Introduction and Business Overview
  • 7.1.3 Medtronic Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Medtronic Demineralized Allografts Product Offerings
  • 7.1.5 Medtronic Recent Development
• 7.2 J &J (DePuy Synthes)
  • 7.2.1 J &J (DePuy Synthes) Company Information
  • 7.2.2 J &J (DePuy Synthes) Introduction and Business Overview
  • 7.2.3 J &J (DePuy Synthes) Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 J &J (DePuy Synthes) Demineralized Allografts Product Offerings
  • 7.2.5 J &J (DePuy Synthes) Recent Development
• 7.3 Zimmer
  • 7.3.1 Zimmer Company Information
  • 7.3.2 Zimmer Introduction and Business Overview
  • 7.3.3 Zimmer Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Zimmer Demineralized Allografts Product Offerings
  • 7.3.5 Zimmer Recent Development
• 7.4 Stryker Corporation
  • 7.4.1 Stryker Corporation Company Information
  • 7.4.2 Stryker Corporation Introduction and Business Overview
  • 7.4.3 Stryker Corporation Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 Stryker Corporation Demineralized Allografts Product Offerings
  • 7.4.5 Stryker Corporation Recent Development
• 7.5 Straumann
  • 7.5.1 Straumann Company Information
  • 7.5.2 Straumann Introduction and Business Overview
  • 7.5.3 Straumann Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Straumann Demineralized Allografts Product Offerings
  • 7.5.5 Straumann Recent Development
• 7.6 RTI Surgical
  • 7.6.1 RTI Surgical Company Information
  • 7.6.2 RTI Surgical Introduction and Business Overview
  • 7.6.3 RTI Surgical Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 RTI Surgical Demineralized Allografts Product Offerings
  • 7.6.5 RTI Surgical Recent Development
• 7.7 Wright Medical Group
  • 7.7.1 Wright Medical Group Company Information
  • 7.7.2 Wright Medical Group Introduction and Business Overview
  • 7.7.3 Wright Medical Group Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Wright Medical Group Demineralized Allografts Product Offerings
  • 7.7.5 Wright Medical Group Recent Development
• 7.8 SeaSpine
  • 7.8.1 SeaSpine Company Information
  • 7.8.2 SeaSpine Introduction and Business Overview
  • 7.8.3 SeaSpine Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.8.4 SeaSpine Demineralized Allografts Product Offerings
  • 7.8.5 SeaSpine Recent Development
• 7.9 Xtant Medical
  • 7.9.1 Xtant Medical Company Information
  • 7.9.2 Xtant Medical Introduction and Business Overview
  • 7.9.3 Xtant Medical Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.9.4 Xtant Medical Demineralized Allografts Product Offerings
  • 7.9.5 Xtant Medical Recent Development
• 7.10 Hans Biomed
  • 7.10.1 Hans Biomed Company Information
  • 7.10.2 Hans Biomed Introduction and Business Overview
  • 7.10.3 Hans Biomed Demineralized Allografts Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.10.4 Hans Biomed Demineralized Allografts Product Offerings
  • 7.10.5 Hans Biomed Recent Development

8 Industry Chain Analysis

• 8.1 Demineralized Allografts Industrial Chain
• 8.2 Demineralized Allografts Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Demineralized Allografts Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Demineralized Allografts Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer